Can you provide the last earnings date for PHIBRO ANIMAL HEALTH CORP-A?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) last reported earnings on 2/4/2026.
PHIBRO ANIMAL HEALTH CORP-A (PAHC) Earnings History & Surprises
NASDAQ:PAHC • US71742Q1067
Current stock price
57.01 USD
+1.53 (+2.76%)
At close:
57 USD
-0.01 (-0.02%)
After Hours:
PAHC Earnings overview
Past quarterly earnings results for PHIBRO ANIMAL HEALTH CORP-A (PAHC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q3 / 2026
- EPS Estimate
- $0.73
- Revenue Estimate
- 372.51M
Last Reported
Most Recent- Release Date
- Feb 4, 2026
- Period
- Q2 / 2026
- EPS Reported
- $0.87
- EPS Surprise
- 27.30%
- Revenue Surprise
- 3.07%
Beat Rate
Last 8 Quarters 88%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 0.87 | 0.68 | 27.30% | 61.11% | 373.9M | 362.75M | 3.07% | 20.89% |
| Q1 2026 | 0.73 | 0.63 | 14.97% | 108.57% | 363.893M | 353.9M | 2.82% | 39.74% |
| Q4 2025 | 0.57 | 0.53 | 7.47% | 39.02% | 378.7M | 369.48M | 2.50% | 38.62% |
| Q3 2025 | 0.63 | 0.53 | 18.78% | 103.23% | 347.8M | 359.45M | -3.24% | 32.14% |
| Q2 2025 | 0.54 | 0.43 | 24.57% | 63.64% | 309.3M | 309.92M | -0.20% | 23.77% |
| Q1 2025 | 0.35 | 0.25 | 38.92% | 150.00% | 260.4M | 249.29M | 4.46% | 12.56% |
| Q4 2024 | 0.41 | 0.34 | 20.59% | 7.89% | 273.2M | 268.51M | 1.75% | 7.14% |
| Q3 2024 | 0.31 | 0.30 | 4.80% | 6.90% | 263.2M | 259.92M | 1.26% | 7.12% |
| Q2 2024 | 0.33 | 0.29 | 15.65% | -2.94% | 249.9M | 247.14M | 1.12% | 2.17% |
| Q1 2024 | 0.14 | 0.23 | -40.32% | -33.33% | 231.349M | 246.88M | -6.29% | -0.50% |
| Q4 2023 | 0.38 | 0.39 | -3.05% | 46.15% | 255M | 261.25M | -2.39% | -0.12% |
| Q3 2023 | 0.29 | 0.34 | -15.13% | -12.12% | 245.7M | 252.41M | -2.66% | 2.55% |
| Q2 2023 | 0.34 | 0.31 | 10.01% | -8.11% | 244.6M | 246.11M | -0.61% | 5.11% |
| Q1 2023 | 0.21 | 0.27 | -22.41% | -16.00% | 232.5M | 232.1M | 0.17% | 8.29% |
| Q4 2022 | 0.26 | 0.39 | -33.39% | -18.75% | 255.3M | 250.94M | 1.74% | 15.89% |
| Q3 2022 | 0.33 | 0.36 | -8.43% | -2.94% | 239.6M | 230.79M | 3.82% | 13.18% |
| Q2 2022 | 0.37 | 0.33 | 11.04% | 8.82% | 232.7M | 221.48M | 5.07% | 12.91% |
| Q1 2022 | 0.25 | 0.30 | -16.44% | -7.41% | 214.7M | 205.74M | 4.36% | 9.99% |
| Q4 2021 | 0.32 | 0.32 | 0.47% | 88.24% | 220.3M | 217.73M | 1.18% | 18.50% |
| Q3 2021 | 0.34 | 0.34 | -0.68% | -10.53% | 211.7M | 212.21M | -0.24% | 0.47% |
| Q2 2021 | 0.34 | 0.27 | 24.84% | - | 206.1M | 210.49M | -2.09% | -3.69% |
| Q1 2021 | 0.27 | 0.24 | 13.51% | 42.11% | 195.2M | 192.86M | 1.21% | 2.90% |
| Q4 2020 | 0.17 | 0.22 | -24.04% | - | 185.9M | 192.68M | -3.52% | - |
| Q3 2020 | 0.38 | 0.35 | 9.64% | - | 210.7M | 212.43M | -0.81% | - |
| Q2 2020 | 0.34 | 0.29 | 16.80% | - | 214M | 223.26M | -4.15% | - |
| Q1 2020 | 0.19 | 0.25 | -22.77% | - | 189.7M | 203.66M | -6.85% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
17.13%
Max EPS beat (4)
27.30%
Min EPS beat (4)
7.47%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
1.29%
Max Revenue beat (4)
3.07%
Min Revenue beat (4)
-3.24%
Analysis
In the last 4 quarters, PAHC has consistently beaten EPS estimates in all releases
PAHC has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, PAHC has beaten the EPS estimates by 17.1% on average.
In the last 4 quarters, PAHC has beaten the revenue estimates by 1.3% on average.
Related analysis
PHIBRO ANIMAL HEALTH CORP-A / PAHC Earnings FAQ
Did PHIBRO ANIMAL HEALTH CORP-A (PAHC) beat earnings estimates last quarter?
PHIBRO ANIMAL HEALTH CORP-A (PAHC) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often PHIBRO ANIMAL HEALTH CORP-A beats earnings estimates?
In the last 4 quarters, PHIBRO ANIMAL HEALTH CORP-A (PAHC) has beaten EPS estimates in 4 out of 4 releases.